Being in-network with Aetna and Cigna will now allow Clarity Clinic to expand access to their Partial Hospitalization (PHP) and Intensive Outpatient (IOP) programs, ensuring more individuals receive the high-quality care they need for their recovery journey.

Educational conference focused on diagnosis, research and treatment of rare neuroimmune disorders

Jerry Carter and Mackenzie Laughridge Join to Drive Growth and Expand Virtual Nursing Solutions

The second volume of Integrate™ magazine highlights everything from surgical guides and immediate implant placement to incision line opening and stem cell technology.

Quest International’s Expanded FCA Resources Offer Medical Device OEMs Timely, Reliable Support Amid Rising FDA Recalls

McNamara’s extensive experience in scaling imaging and eClinical companies through organic growth and acquisition strategies brings a wealth of expertise to accelerate Yunu’s life sciences business. 

ASTCT® and CIBMTR® Bring Leading Experts Together to Share Groundbreaking Advancements in Hematopoietic Cell Transplantation, Cellular Therapy and Gene Therapy.

Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable disease

Colon cancer patient achieved stable disease and remained on study for more than six months, breast cancer patient remained on study for more than 11 months

Biomarker analysis confirms immune activation in the tumor microenvironment

Data Presented at Society for Immunotherapy of Cancer on November 8, 2024

Training for the proprietary program is aimed at implementing the latest evidenced-based approaches to dementia care amid the growing numbers of Americans affected.

IRB approval on track as scheduled

Next step is obtaining all regulatory approvals, followed by site initiation visit

VELDONA significantly increases unstimulated whole salivary flow in prior Phase 3 studies

As the country is in the midst of a clinician shortage, Fusion has launched an app that will help connect travel healthcare professionals to facilities across the country needing help. 

The Next Age-Defiers You Haven't Heard of Yet
A giant leap into a new era of body rejuvenation.

• Meet with Modular Medical CEO, Jeb Besser

• Obesity is linked to 30% to 53% of new diabetes cases in the U.S. every year, per research in the Journal of the American Heart Association

• About half of all patients prescribed a GLP-1 drug for weight loss discontinued after the first 12 weeks, with approximately 30% discontinuing in the first four weeks

• Discover Modular Medical's Recently Announced Results from a Successful GLP-1 Proof of Concept Study

Achieved Record Revenue and Growth of 41%; Operational Cash Burn Reduced to $1.2 Million

Iodine Software earned the highest industry client satisfaction ranking for informatics in the competitive mid-RCM market with top customer-rated utilization management, computer-assisted medical documentation, clinical coding and documentation integrity, and proven artificial intelligence tools.

Dr. Naba Sharif set to lead initiatives for enhanced allergy and asthma care for New Jersey residents.

REMORY: Elevate Cognitive Health with Unique Sea Squirt-Derived Plasmalogens. Now in the U.S., this Japanese-Innovated Supplement Combines EPA, DHA, and Omega-3s for Enhanced Memory and Brain Function in Aging Adults. Recognized by Japan as a 'Food with Functional Claims,' REMORY is FDA-Notified, Setting a New Standard in Natural Cognitive Support.

• Revenue increased 31% for the quarter compared to same period prior year

• Positive cash flows from operations of $0.35 million for the quarter

• Net loss improved 59% for the quarter compared to same period prior year

• Net loss per share improved 90% for the quarter compared to same period prior year

-Study showed more potent weight loss and blood glucose control with the addition of a mealtime bolus of a rapid acting GLP-1 to basal delivery

- Observed weight loss was 17% at 28 days, a 25% improvement over GLP-1 delivered as basal alone

-Findings suggest that pump delivery may be a viable approach to achieve GLP-1 weight and blood glucose benefits that are comparable with current treatment standards, either as initial treatment or for maintenance, while bringing personalized dosing flexibility

Split Becomes Effective Monday, November 11, 2024

Shareholder- and Board-Approved Action Reduces Shares Outstanding to 313,235 from 31 Million, Ensures Continued Compliance with Nasdaq Listing Requirements

Reports third quarter revenues of $1.9 billion, GAAP net income of $13 million and GAAP EPS of $0.03

Achieves year-to-date product sales of $2.2 billion; reiterates 2024 expected product sales of $3.0 to $3.5 billion

Initiated dosing in two pivotal Phase 3 trials to assess efficacy of investigational mRNA vaccines against norovirus and influenza

Announces expansion of its Executive Committee

Secured multi-regional patent assets, strengthening Ainos' AI Nose technology.

Expanded VELDONA® patent portfolio with a new invention patent for treatments and preventions for coronavirus infections.

Progressed clinical trials for VELDONA®, including new studies on Sjögren's syndrome and HIV-related oral warts.

Third Holland Foundation Center of Excellence To Be Established

AI-Driven Platform and Strategic Acquisitions to Drive Health & Wellness Growth and Profitability

Just a short train ride from Manhattan or a scenic drive along the Merritt Parkway, visitors can find ESSE Care’s new location at Exit 31 on North Street, set amidst the serene backdrop of back-country Greenwich.

The Behavioral Health Tech 2024 (BHT2024) conference is a premier event dedicated to advancing access to mental health, substance use, and intellectual and developmental disability (IDD) care through technology, health equity, and innovation. Scheduled for November 5th to 7th, 2024, the conference will be held at the Arizona Biltmore, LXR Hotels & Resorts in Phoenix, Arizona.

Smile Digital Health is supporting NCQA to expand the digital transformation of HEDIS® through their Smile dQM Innovation Program for NCQA Digital Content Services Early Adopters

Setting New Standards in Workers' Compensation Documentation